Yahoo Web Search

Search results

1. • 

     Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief

     Verywell Health via Yahoo News· 6 days ago

     Takeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...

2. • Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%

     ETF DAILY NEWS· 2 days ago

     Shares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...

3. • Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.

     Morningstar· 6 days ago

     “We are proud to make SIMLANDI available in the U.S. to...

4. • 

     J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial

     Clinical Trials Arena via Yahoo Finance· 6 days ago

     J&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...

5. • 

     What To Know and Do About Jaw Pain on One Side

     Health via Yahoo News· 23 hours ago

     You may also have discomfort in the neck, back, and stomach. Cancer: Oral cancer can cause one-sided jaw pain, difficulty moving your mouth, and swelling...

6. • 

     High NSAID Use for axSpA May Not Raise Risk for Hypertension

     Medscape· 5 hours ago

     There was no difference in the risk for hypertension between patients with axial spondylarthritis...

7. • TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...

     FOX 23 News Albany· 7 days ago

     WASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...

8. • 

     Guselkumab Continues Winning Streak in Crohn's Disease

     MedPage Today· 5 days ago

     Induction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...

9. • AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review

     ETF DAILY NEWS· 2 days ago

     AbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...

10. • 

      Maintenance Tx With Guselkumab for UC Meets All Endpoints

      Medscape· 5 days ago

      Guselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...